Patent · US Expired

Device for aerosolized delivery of peptide drugs

US5960792A · kind A · utility

231Cited by
22References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 1995
Grant dateOct 5, 1999
Priority date
Expiry dateOct 27, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/8206
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method of treating human patients is provided by the intrapulmonary delivery of a pharmaceutically active peptide formulation. The formulation is automatically released in an aerosolized form from a hand-held, self-contained, portable device comprised of a means for automatically releasing a measured amount of drug into the inspiratory flow path of a patient in response to information obtained from a means for measuring the inspiratory flow rate and determining the inspiratory volume of a patient. Reproducible dosing is obtained by providing for automatic release at the same inspiratory flow rate and inspiratory volume each time drug is released. The device includes a timer to enable a patient to take a drug at the same time each day. Further, overadministration of hormone formulations is avoided by providing a pre-programmed microprocessor designed to avoid overdosing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.